Metys Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Metys Pharmaceuticals Ownership

Who owns Metys Pharmaceuticals?

Metys Pharmaceuticals is owned by Novaremed AG. It was acquired on September 7, 2021.

Metys Pharmaceuticals Business Overview

Where is Metys Pharmaceuticals headquartered?

Metys Pharmaceuticals is headquartered in Basel, Switzerland.

What sector is Metys Pharmaceuticals in?

Metys Pharmaceuticals is a life science company.

When was Metys Pharmaceuticals founded?

Metys Pharmaceuticals was founded in 2013.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 387 acquisitions of life science companies in 2021, including 43 acquisitions by private equity firms, and 344 by strategics.

Metys Pharmaceuticals

Metys Pharmaceuticals AG

Gerbergasse 30,
Basel, CH-4001
Switzerland,
+41-79-408-7982
www.metys-pharma.ch

Metys Pharmaceuticals is a biopharmaceutical company developing MP-101 to prevent and treat chemotherapy-induced peripheral neuropathy, an uncomfortable and troubling side effect of several important cancer treatments. Metys Pharmaceuticals was founded in 2013 and is based in Basel, Switzerland.


 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Metys Pharmaceuticals

Life Science Companies , Switzerland Companies